JPWO2023158990A5 - - Google Patents
Info
- Publication number
- JPWO2023158990A5 JPWO2023158990A5 JP2024548391A JP2024548391A JPWO2023158990A5 JP WO2023158990 A5 JPWO2023158990 A5 JP WO2023158990A5 JP 2024548391 A JP2024548391 A JP 2024548391A JP 2024548391 A JP2024548391 A JP 2024548391A JP WO2023158990 A5 JPWO2023158990 A5 JP WO2023158990A5
- Authority
- JP
- Japan
- Prior art keywords
- eye
- sequence
- raav particles
- unit dose
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263310865P | 2022-02-16 | 2022-02-16 | |
| US63/310,865 | 2022-02-16 | ||
| US202263316705P | 2022-03-04 | 2022-03-04 | |
| US63/316,705 | 2022-03-04 | ||
| PCT/US2023/062531 WO2023158990A1 (en) | 2022-02-16 | 2023-02-14 | Method of reducing cst fluctuation in neovascular amd by a recombinant adeno-associated virus |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025506681A JP2025506681A (ja) | 2025-03-13 |
| JP2025506681A5 JP2025506681A5 (https=) | 2026-02-24 |
| JPWO2023158990A5 true JPWO2023158990A5 (https=) | 2026-02-24 |
Family
ID=85570182
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024548391A Pending JP2025506681A (ja) | 2022-02-16 | 2023-02-14 | 組み換えアデノ随伴ウイルスによる血管新生ａｍｄにおけるｃｓｔ変動の低減方法 |
Country Status (8)
| Country | Link |
|---|---|
| EP (2) | EP4479098A1 (https=) |
| JP (1) | JP2025506681A (https=) |
| KR (1) | KR20240161978A (https=) |
| AU (1) | AU2023221321A1 (https=) |
| CA (1) | CA3244250A1 (https=) |
| IL (1) | IL314762A (https=) |
| MX (1) | MX2024010002A (https=) |
| WO (1) | WO2023158990A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118718181A (zh) | 2019-06-05 | 2024-10-01 | 里珍纳龙药品有限公司 | 用于精确剂量递送的装置及方法 |
| USD1120314S1 (en) | 2022-11-30 | 2026-03-24 | Regeneron Pharmaceuticals, Inc. | Dose delivery device |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20171334T1 (hr) | 2011-04-22 | 2017-11-17 | The Regents Of The University Of California | Virioni adeno-povezanog virusa s kapsid varijantom i postupci njihove upotrebe |
| CN110546257B (zh) | 2017-03-17 | 2024-03-01 | 阿德夫拉姆生物技术股份有限公司 | 用于增强基因表达的组合物和方法 |
| FI4027983T3 (fi) * | 2019-09-11 | 2026-02-03 | Adverum Biotechnologies Inc | Silmän neovaskulaaristen sairauksien hoito afliberseptiä koodaavilla aav2-varianteilla |
| WO2021050094A1 (en) * | 2019-09-11 | 2021-03-18 | Adverum Biotechnologies, Inc. | Methods of treating ocular neovascular diseases using aav2 variants encoding aflibercept |
-
2023
- 2023-02-14 EP EP23710626.5A patent/EP4479098A1/en not_active Withdrawn
- 2023-02-14 AU AU2023221321A patent/AU2023221321A1/en active Pending
- 2023-02-14 WO PCT/US2023/062531 patent/WO2023158990A1/en not_active Ceased
- 2023-02-14 IL IL314762A patent/IL314762A/en unknown
- 2023-02-14 CA CA3244250A patent/CA3244250A1/en active Pending
- 2023-02-14 KR KR1020247030971A patent/KR20240161978A/ko active Pending
- 2023-02-14 EP EP25188887.1A patent/EP4682163A3/en active Pending
- 2023-02-14 JP JP2024548391A patent/JP2025506681A/ja active Pending
-
2024
- 2024-08-15 MX MX2024010002A patent/MX2024010002A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI4027983T3 (fi) | Silmän neovaskulaaristen sairauksien hoito afliberseptiä koodaavilla aav2-varianteilla | |
| US20240327481A1 (en) | Growth differentiation factor 15 fusion proteins | |
| JP2021503914A5 (https=) | ||
| FI3717636T3 (fi) | Adenoassosioidun viruksen kapsidivariantteja ja käyttö angiogeneesin estämisessä | |
| RU2018142768A (ru) | Варианты капсидов аденоассоциированного вируса и способы их применения | |
| EP3215123A1 (en) | Methods for treating ocular diseases | |
| JP2021511030A5 (https=) | ||
| US20220323587A1 (en) | Dissolvable films and methods of their use | |
| JPWO2021050649A5 (https=) | ||
| JPWO2023158990A5 (https=) | ||
| JPWO2022232790A5 (https=) | ||
| US12233113B2 (en) | Pharmaceutical composition comprising recombinant hGH for the treatment of growth hormone deficiency | |
| JPWO2023150566A5 (https=) | ||
| JPWO2019138137A5 (https=) | ||
| JP2025542123A (ja) | 眼送達のための医薬組成物 | |
| JPWO2020180951A5 (https=) | ||
| JPWO2021041373A5 (https=) | ||
| JPH0995455A (ja) | 腎機能改善剤 | |
| JPWO2022232141A5 (https=) | ||
| JP2025084976A5 (https=) | ||
| Kirkner | Pipeline report: new entries continue to exceed exits | |
| Chan | Association for Research in Vision and Ophthalmology (ARVO) 2017 Annual Meeting. Baltimore, Maryland, USA-May 7-11, 2017 | |
| JP2025084977A5 (https=) | ||
| CN120227455A (zh) | 包含与乙型肝炎病毒表面抗原（HBsAg）特异性结合的抗体组合物 | |
| RU2023130643A (ru) | Композиции и способы для лечения заболевания глаз, ассоциированного с ангиогенезом |